Curcumin molecular targets in obesity and obesity-related cancers

Future Oncology
Adeeb ShehzadYoung Sup Lee

Abstract

Obesity is characterized as an increased BMI, which is associated with the increased risk of several common cancers, including colorectal, breast, endometrial, renal, esophageal, gallbladder, melanoma, multiple myeloma, leukemia, lymphoma and prostate cancer. The increased risk of obesity-related cancers could be mediated by insulin resistance, adipokines, obesity-related inflammatory cytokines, sex hormones, transcription factors and oxidative stress, which disrupt the balance between cell proliferation and apoptosis. The yellowish compound, curcumin (diferuloylmethane), is known to possess multifaceted pharmacological effects. The molecular mechanisms linking obesity to cancer risk, and how curcumin mediates anticancer and obesity activities, have not yet been publicized. Curcumin modulates multiple molecular targets and reverses insulin resistance as well as other symptoms that are associated with obesity-related cancers. In this study, we show that ample evidence exists to support recommendations that curcumin mediates multiple molecular pathways, and is considered to be of therapeutic value in the treatment and prevention of obesity-related cancers.

References

Feb 22, 2002·International Journal of Cancer. Journal International Du Cancer·Zhi-Ming ShaoMai Nguyen
May 22, 2002·Cellular Signalling·Gary Sweeney
Feb 7, 2003·The Biochemical Journal·Elisabeth BalogunRoberto Motterlini
Feb 25, 2003·Nature Cell Biology·Miyuki SuzawaShigeaki Kato
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anne McTiernanRachel Ballard-Barbash
Jun 13, 2003·Nature·Toshimasa YamauchiTakashi Kadowaki
Jul 29, 2003·Diabetes Care·Manju ChandranRobert R Henry
Aug 21, 2003·Journal of the National Cancer Institute·T J KeyUNKNOWN Endogenous Hormones Breast Cancer Collaborative Group
Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ebba BråkenhielmYihai Cao
Oct 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ricky A SharmaWilliam P Steward
Nov 25, 2005·American Journal of Physiology. Gastrointestinal and Liver Physiology·Shizhong Zheng, Anping Chen
Mar 16, 2006·Toxicological Sciences : an Official Journal of the Society of Toxicology·Jun CaoLai-Fu Zhong
Mar 21, 2006·BMC Complementary and Alternative Medicine·Christopher D LaoDean E Brenner
May 23, 2006·The Journal of Nutritional Biochemistry·Dieter PeschelNorbert Nass
Sep 8, 2006·Trends in Endocrinology and Metabolism : TEM·Andrew G RenehanAllan Flyvbjerg
Sep 26, 2006·Nature Reviews. Immunology·Herbert Tilg, Alexander R Moschen
Oct 31, 2006·The American Journal of Pathology·Stephanie Cowey, Robert W Hardy
Jan 5, 2007·Biological & Pharmaceutical Bulletin·Poorichaya SomparnNoppawan Phumala Morales
Mar 21, 2007·Laboratory Investigation; a Journal of Technical Methods and Pathology·Yajun ZhouAnping Chen
Sep 27, 2007·International Journal of Obesity : Journal of the International Association for the Study of Obesity·M E RauschD V Tortoriello
Oct 24, 2007·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Larry BaumChristopher W K Lam
Apr 19, 2008·American Journal of Respiratory Cell and Molecular Biology·Koremu K MejaIrfan Rahman
Jun 14, 2008·Nutrition & Metabolism·Amanda M Gonzales, Robert A Orlando
Jul 8, 2008·Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine·Xiao-bing QuLi-ni Dong
Sep 9, 2008·Biochemical Pharmacology·Preetha AnandBharat B Aggarwal
Oct 23, 2008·Metabolism: Clinical and Experimental·Eun-Mi JangMi-Kyung Lee
Nov 26, 2008·Nature Reviews. Cancer·Michael Pollak
Aug 18, 2009·British Journal of Pharmacology·Annette Graham
Oct 15, 2009·Annual Review of Medicine·Darren L RobertsAndrew G Renehan
Oct 16, 2009·Journal of Cardiovascular Medicine·David Siu
Feb 4, 2010·International Journal of Cancer. Journal International Du Cancer·Kuo-Wei ChangShu-Chun Lin

❮ Previous
Next ❯

Citations

Apr 17, 2013·Apoptosis : an International Journal on Programmed Cell Death·Sun Hee ParkSteven M Frisch
Dec 12, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hui-Jie FanYan-Ru Qin
Jul 28, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Zhen-Cai LiJun-Zhong Sun
May 27, 2014·Expert Opinion on Drug Delivery·Wing-Hin LeeRamin Rohanizadeh
Mar 11, 2016·BoneKEy Reports·Ramin RohanizadehElise Verron
Jan 11, 2013·BioFactors·Adeeb ShehzadYoung Sup Lee
Nov 12, 2013·Cytokine & Growth Factor Reviews·Sajid KhanSyed Musthapa Meeran
Jul 11, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Guo-Shiou LiaoLie-Fen Shyur
Jul 30, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yunes PanahiAmirhossein Sahebkar
Jan 21, 2017·Journal of Cellular Biochemistry·Muhammad TariqBo Yang
May 24, 2013·International Journal of Molecular Sciences·Isabella SaviniLuciana Avigliano
Mar 29, 2014·Archiv der Pharmazie·Gauhar RehmanMuhammad Hamayun
Jul 31, 2019·Expert Opinion on Drug Metabolism & Toxicology·Ajaikumar B KunnumakkaraBharat B Aggarwal
May 14, 2020·Natural Product Reports·Donna D Zhang, Eli Chapman
Aug 5, 2017·Journal of Food Science·Adeeb ShehzadYoung Sup Lee
Jan 1, 2014·International Journal of Chronic Diseases·Abdulrahman Saleh Al-MulhimSara Abdullah Al-Najjar
Mar 7, 2021·International Journal of Molecular Sciences·Israel Pérez-TorresVerónica Guarner-Lans

❮ Previous
Next ❯

Methods Mentioned

BETA
chromosomal aberrations

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.